Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Matrix metalloproteinase -9 polymorphism and outcome after acute myocardial infarction.

El-Aziz TAA, Mohamed RH.

Int J Cardiol. 2017 Jan 15;227:524-528. doi: 10.1016/j.ijcard.2016.10.109. Epub 2016 Nov 2.

PMID:
27825726
2.

Matrix Metalloproteinase 3 Gene Polymorphism and Its Level Predict Morbidity After Acute Myocardial Infarction.

Abd El-Aziz TA, Mohamed RH.

Am J Clin Pathol. 2016 Jan;145(1):134-9. doi: 10.1093/ajcp/aqv008.

PMID:
26712881
3.

Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study.

Kelly D, Cockerill G, Ng LL, Thompson M, Khan S, Samani NJ, Squire IB.

Eur Heart J. 2007 Mar;28(6):711-8. Epub 2007 Mar 5.

4.

The Relationship Between MMP-2 -1306C>T and MMP-9 -1562C>T Polymorphisms and the Risk and Prognosis of T-Cell Acute Lymphoblastic Leukemia in a Chinese Population: A Case-Control Study.

Lin CM, Zeng YL, Xiao M, Mei XQ, Shen LY, Guo MX, Lin ZY, Liu QF, Yang T.

Cell Physiol Biochem. 2017;42(4):1458-1468. doi: 10.1159/000479210. Epub 2017 Jul 18.

5.

Interaction between MMP-9 gene polymorphisms and smoking in relation to myocardial infarction in a Uighur population.

Wang L, Ma YT, Xie X, Yang YN, Fu ZY, Li XM, Liu F, Huang Y, Ma X, Chen BD, Yuan S, Sun MH, Peng X, Wang BZ.

Clin Appl Thromb Hemost. 2012 Jan-Feb;18(1):72-8. doi: 10.1177/1076029611412365. Epub 2011 Jul 6.

PMID:
21733941
6.
7.

Genetic polymorphisms and plasma levels of matrix metalloproteinases and their relationships with developing acute myocardial infarction.

Ghaderian SM, Akbarzadeh Najar R, Tabatabaei Panah AS.

Coron Artery Dis. 2010 Sep;21(6):330-5. doi: 10.1097/MCA.0b013e32833ce065.

PMID:
20616708
8.

A close relationship between functional polymorphism in the promoter region of matrix metalloproteinase-9 and acute myocardial infarction.

Koh YS, Chang K, Kim PJ, Seung KB, Baek SH, Shin WS, Lim SH, Kim JH, Choi KB.

Int J Cardiol. 2008 Jul 21;127(3):430-2. Epub 2007 Aug 14.

PMID:
17698228
9.

Predictive utility of the changes in matrix metalloproteinase-2 in the early phase for left ventricular reverse remodeling after an acute myocardial infarction.

Morishita T, Uzui H, Mitsuke Y, Arakawa K, Amaya N, Kaseno K, Ishida K, Nakaya R, Lee JD, Tada H.

J Am Heart Assoc. 2015 Jan 23;4(1):e001359. doi: 10.1161/JAHA.114.001359.

10.

Influences of IL-1b-3953 C>T and MMP-9-1562C >T Gene Variants on Myocardial Infarction Susceptibility in a Subset of the Iranian Population.

Daraei A, Mansoori Y, Zendebad Z, Tavakkoly-Bazzaz J, Madadizadeh F, Naghizadeh MM, Arghavani A, Mansoori B.

Genet Test Mol Biomarkers. 2017 Jan;21(1):33-38. doi: 10.1089/gtmb.2016.0240. Epub 2016 Nov 8.

PMID:
27824519
11.

The co-existence of the IL-18+183 A/G and MMP-9 -1562 C/T polymorphisms is associated with clinical events in coronary artery disease patients.

Opstad TB, Pettersen AÅ, Arnesen H, Seljeflot I.

PLoS One. 2013 Sep 5;8(9):e74498. doi: 10.1371/journal.pone.0074498. eCollection 2013.

12.

PPARgamma gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expression.

Liu Y, Yuan Z, Liu Y, Zhang J, Yin P, Wang D, Wang Y, Kishimoto C, Ma A.

Am Heart J. 2007 Oct;154(4):718-24. Epub 2007 Aug 27.

PMID:
17892998
13.
14.

Usefulness of plasma matrix metalloproteinase-9 level in predicting future coronary revascularization in patients after acute myocardial infarction.

Wang KF, Huang PH, Chiang CH, Hsu CY, Leu HB, Chen JW, Lin SJ.

Coron Artery Dis. 2013 Jan;24(1):23-8. doi: 10.1097/MCA.0b013e32835aab4a.

PMID:
23151854
15.

Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.

Montaner J, Fernández-Cadenas I, Molina CA, Monasterio J, Arenillas JF, Ribó M, Quintana M, Chacón P, Andreu AL, Alvarez-Sabín J.

Stroke. 2003 Dec;34(12):2851-5. Epub 2003 Nov 6.

PMID:
14605329
17.

Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease.

Opstad TB, Pettersen AA, Weiss TW, Akra S, Øvstebø R, Arnesen H, Seljeflot I.

Clin Chim Acta. 2012 Jan 18;413(1-2):113-20. doi: 10.1016/j.cca.2011.09.004. Epub 2011 Sep 22.

PMID:
21963461
18.

C(-260)T Polymorphism in CD14 Receptor Gene of Egyptians with Acute Myocardial Infarction.

Hashad IM, Hossni NM, Abdel Rahman MF, Shehata M, Shaban G, Gad MZ.

Curr Pharm Biotechnol. 2018;19(4):336-342. doi: 10.2174/1389201019666180605125803.

PMID:
29874995
19.

Association of Thrombospondin-1 (N700S) and Thrombospondin-4 (A387P) Gene Polymorphisms with the Incidence of Acute Myocardial Infarction in Egyptians

Abdelmonem NA, Turky NO, Hashad IM, Abdel Rahman MF, El-Etriby A, Gad MZ.

Curr Pharm Biotechnol. 2017;18(13):1078-1087. doi: 10.2174/1389201019666180115144028.

PMID:
29336258
20.

Role of proinflammatory alleles in longevity and atherosclerosis: results of studies performed on -1562C/T MMP-9 in centenarians and myocardial infarction patients from Sicily.

Nuzzo D, Vasto S, Balistreri CR, Di-Carlo D, Listì F, Caimi G, Caruso M, Hoffmann E, Incalcaterra E, Lio D, Caruso C, Candore G.

Ann N Y Acad Sci. 2006 Nov;1089:496-501.

PMID:
17261792

Supplemental Content

Support Center